Tetra Bio-Pharma Inc.
TBPMQ
$0.00
$0.000.00%
OTC PK
| 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 7.40% | -128.63% | 94.68% | -418.39% | 26.93% |
| Total Depreciation and Amortization | -1.73% | 0.00% | -39.51% | 33.64% | -20.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.38% | 104.48% | -98.72% | 5,220.69% | -69.34% |
| Change in Net Operating Assets | 113.83% | 198.75% | -161.75% | 177.90% | 50.48% |
| Cash from Operations | 55.08% | 19.80% | 21.31% | 60.57% | 30.87% |
| Capital Expenditure | -- | -- | -- | 88.52% | -99.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -1,493.45% | 94.39% |
| Cash from Investing | -- | -- | -- | -386.07% | 82.44% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 24.01% | 13.36% | -- | -- | 100.00% |
| Issuance of Common Stock | -100.00% | -76.52% | -- | -100.00% | -99.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 94.69% | -- | -- | 100.00% |
| Cash from Financing | -1,953.15% | -101.55% | -- | -100.00% | -99.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.23% | -59.32% | 67.43% | 52.30% | -150.15% |